Abstract:Electronic cigarettes (e-cigs) are popular nicotine delivery devices, yet the health effects remain unclear. To determine equivalent biomarkers, we characterized the immediate response in Apoe −/− mice exposed to tank/box-mod e-cig (e-cig tank ), pod e-cig (e-cig pod ), or cig smoke. Reproducible puff profiles were generated for each aerosol and delivered to Apoe −/− mice via a nose-only exposure system. Serum cotinine levels were quantified at various time points through ELISA and utilized to model cotinine pharmacokinetics. In addition, particle size measurements and mouse respiratory function were characterized to calculate particle dosimetry. Cig and e-cig tank particles were lognormally distributed with similar count median diameters (cig: 178 ± 2, e-cig tank : 200 ± 34nm), while e-cig pod particles were bimodally distributed and smaller (116 ± 13 and 13.3 ± 0.4 nm). Minute volumes decreased with cig exposure (5.4 ± 2.7 mL/min) compared to baseline (90.8 ± 11.6 mL/min), and less so with e-cig tank (45.2 ± 9.2 mL/min) and e-cig pod exposures (58.6 ± 6.8 mL/min), due to periods of apnea in the cig exposed groups. Cotinine was absorbed and eliminated most rapidly in the e-cig pod group ( tmax = 14.5; t1/2' = 51.9 min), whereas cotinine was absorbed (cig: 50.4, e-cig tank : 40.1 min) and eliminated (cig: 104.6, e-cig tank : 94.1 min) similarly in the cig and e-cig tank groups. For exposure times which equate the area under the cotinine-concentration curve, ∼6.4× (e-cig tank ) and 4.6× (e-cig pod ) more nicotine deposited in e-cig compared to cig exposed mice. This study provides a basis for incorporating cotinine pharmacokinetics into preclinical exposure studies, allowing for longitudinal studies of structural and functional changes due to exposure. This study highlights that pod e-cigs deliver smaller particles than tank/box-mode e-cigs and cig smoke. Minute volumes were substantially reduced in cig smoke-exposed mice, due to periods of apnea, whereas only expiration times increased in the e-cig-exposed groups. More particles deposit in e-cig exposed mice, compared to the cig group, for equivalent daily area under the cotinine concentration curve.

Pharmacokinetic Analysis of Nicotine and Its Metabolites (Cotinine and trans-3'-Hydroxycotinine) in Male Sprague-Dawley Rats Following Nose-Only Inhalation, Oral Gavage, and Intravenous Infusion of Nicotine

Pharmacokinetic and pharmacodynamic studies of nicotine in rat brain: a simultaneous investigation of nicotine metabolites and the release of neurotransmitters in vivo

Nicotine Population Pharmacokinetics in Healthy Adult Smokers: A Retrospective Analysis

Mass spectrometry-based metabolomics study of nicotine exposure in THP-1 monocytes

Guidelines on nicotine dose selection for in vivo research

An e-cigarette aerosol generation, animal exposure and toxicants quantification system to characterize in vivo nicotine kinetics in arterial and venous blood

Assessment of nicotine delivery and uptake in users of various tobacco/nicotine products

The effect of cut sizes and pH of tobacco leaf in smokeless tobacco products on the pharmacokinetics of nicotine

Prolonged, physiologically relevant nicotine concentrations in the airways of smokers

Nicotine-N′-Oxidation by Flavin Monooxygenase Enzymes

1H-Nuclear Magnetic Resonance-Based Metabolomic Analysis of Brain in Mice with Nicotine Treatment.

Chronic nicotine treatment induces rat CYP2D in the brain but not in the liver: an investigation of induction and time course.

Quantitation of Ten Urinary Nicotine Metabolites, Including 4-Hydroxy-4-(3-pyridyl) Butanoic Acid, a Product of Nicotine 2'-Oxidation, and CYP2A6 Activity in Japanese Americans, Native Hawaiians, and Whites

Metabolic profiling reveals distinct variations linked to nicotine consumption in humans--first results from the KORA study.

In Vivo And In Vitro Characterization Of Chlorzoxazone Metabolism And Hepatic Cyp2e1 Levels In African Green Monkeys: Induction By Chronic Nicotine Treatment

Pharmacokinetic Profile of Spectrum Reduced Nicotine Cigarettes.

Distribution and metabolism of N'-nitrosonornicotine in the miniature pig

E-Cigarette Aerosol Deposition and Disposition of [11C]Nicotine Using Positron Emission Tomography: A Comparison of Nicotine Uptake in Lungs and Brain Using Two Different Nicotine Formulations

Pharmacological and physiological response in Apoe−/− mice exposed to cigarette smoke or e-cigarette aerosols

CYP2A6 Activity and Its Effect on Nicotine Metabolic Kinetics in Different Metabolic Activation Systems

Assessment of nicotine release from nicotine-loaded chitosan nanoparticles dry powder inhaler formulations via locomotor activity of C57BL/6 mice